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Case ReportParaneoplastic Anti-N-Methyl-D-Apartate-
Receptor Encephalitis Associated With an
Immature Teratoma
A. Mitch Dizon,1 Karen L. Samples,1 Kristopher J. Kimball,2 Larry C. Kilgore2Clinical Practice Points
 Paraneoplastic syndromes are deﬁned as a constel-
lation of symptoms and signs that are not directly
caused by the primary or metastatic cancer.
 Anti-N-Methyl-D-Apartate (NMDA) receptor-mediated
encephalitis is a paraneoplastic syndrome that has
been associated with ovarian teratoma. It is believed
that ectopic neural tissues in teratomas can stimu-
late the immune system to produce antibodies to the
NMDA receptor with resulting encephalitis.
 Anti-NMDA encephalitis is emerging as a more fre-
quently recognized but likely underdiagnosed cause of
neuropsychiatric symptoms and fever of unknown
origin. This disease has high morbidity and mortality
secondary to its often-late diagnosis, but with early
detection and prompt treatment, many of the mani-
festations are reversible.Clinical Ovarian and Other Gynecologic Cancer, Vol. 5, No. 2, 97-8 ª 2014 Elsevier Inc. All rights reserved.
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Paraneoplastic syndromes are deﬁned as a constellation of
symptoms and signs that are not directly caused by the primary or
metastatic cancer.1 Anti-N-Methyl-D-Apartate (NMDA) receptor-
mediated encephalitis is a paraneoplastic syndrome that has been
associated with ovarian teratoma. The NMDA receptor is located in
the hippocampus, and persistent activation has been studied as an
origin of epilepsy, dementia, and stroke. It is believed that ectopic
neural tissues in teratomas can stimulate the immune system to
produce antibodies to the NMDA receptor with resulting enceph-
alitis.3-5 Here we present a case of an immature ovarian teratoma
associated with paraneoplastic encephalitis.
Case Report
A 22-year-old woman (G3P1021) with a past medical history of
bipolar disorder began experiencing hallucinations and demon-
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to a nearby inpatient psychiatric facility. On arrival, the patient was
complaining of headache, actively hallucinating, and treated with
the neuroleptic medications, haldol and thorazine. She proceeded to
exhibit clonic rhythmic movements, muscle rigidity, and became
unresponsive. She was subsequently transferred to our medical
center’s intensive care unit.
On arrival, she was obtunded, febrile at 103.0F, and demon-
strating the same movements as already described. She required
intubation for airway protection. Initial laboratory results revealed a
markedly elevated creatine phosphokinase. A febrile work-up was
performed, including blood cultures, urine culture, and chest x-ray,
and all were negative. Neurologic workup including computed to-
mography (CT) and magnetic resonance imaging (MRI) of the brain
and lumbar puncture were unrevealing. Electroencephalography
showed theta range slowing consistent with toxic or metabolic en-
cephalopathy. Intensive care measures including broad spectrum an-
tibiotics, mechanical ventilation, and nutritional support were
instituted. The patient was given dantrolene and bromocriptine for
the presumed diagnosis of neuroleptic malignant syndrome. She
continued to require ventilator support and developed complications
including ventilator-associated pneumonia and dantrolene-induced
hepatitis. Her prolonged admission and decomposition required tra-
cheostomy and percutaneous endoscopic gastrostomy tube placement.
The patient’s severe encephalopathy persisted and other possible
obscure etiologies were explored. On hospital day 24, a medicalClinical Ovarian and Other Gynecologic Cancer December 2012 - 97
98 -
Anti-NMDA Encephalitis From Immature Teratomaresident’s literature search yielded a case report of encephalopathy as
a result of an immature ovarian teratoma. An abdominal ultrasound
was ordered. A large mass was visualized in the pelvis. Subsequent
MRI suggested the 17.5  15  9 cm mass was consistent with a
left ovarian teratoma. Gynecology was consulted for evaluation and
surgical management. The patient promptly underwent an explor-
atory laparotomy, left salpingo-oopherectomy, and pelvic lymph
node dissection. Intraoperative frozen section revealed a likely
teratoma with predominant glial and neural components. Final
pathology conﬁrmed an immature teratoma with predominately
glial and neural components.
Postoperatively, she received plasmapheresis and corticosteroids.
On postoperative day 6, she was demonstrating minimal neurologic
improvement and then underwent lumbar puncture to help guide
therapy. Her cerebrospinal ﬂuid was positive for anti-NMDA re-
ceptor antibodies. Etoposide and cisplatin chemotherapy were
instituted (bleomycin was held secondary to the patients’ concurrent
bacterial tracheobronchitis). The patient demonstrated clinical
improvement after surgery and chemotherapy. On hospital day 39
she demonstrated purposeful movement, on day 47 she followed
commands, and on day 96 she was discharged to an extended care
facility. At the time of discharge she could recognize family and
respond in conversation. She is currently participating in physical
and occupational therapies at home.
Discussion
Patients with anti-NMDA receptor encephalitis often present
with headache and hyperthermia. Neuropsychiatric symptoms
follow, including anxiety, agitation, hallucinations, and bizarre
behavior. Eventually patients experience further deterioration and
might have seizures, demonstrate movement disorders, autonomic
instability, and hypoventilation. Patients are often admitted to the
intensive care unit and require ventilation before receiving a
diagnosis.1
The differential diagnosis is wide and includes toxic and meta-
bolic disorders, neuroleptic malignant syndrome, serotonin syn-
drome, and autoimmune encephalopathies. The diagnosis is
conﬁrmed by evaluation of cerebral spinal ﬂuid for anti-NMDA
receptor antibodies with the previously described clinical presenta-
tion.1 Unfortunately, before incidental CT scan ﬁnding, an un-
derlying malignancy was not considered during the patient’s initial
evaluation. The ﬁrst evaluation of her cerebrospinal ﬂuid included
only a microbiological analysis, and the second was for detection of
anti-NMDA receptor antibodies. When the diagnosis is conﬁrmed,
a thorough search using available imaging studies should be un-
dertaken to identify the source of antibody production.6 Even smallClinical Ovarian and Other Gynecologic Cancer December 2012teratomas should be removed, and if a thorough radiological search
does not reveal neoplasia in a patient with serology-conﬁrmed anti-
NMDA encephalitis, then the current literature supports surgery
including wedge resection of the ovary to remove teratomas that
might escape detection using imaging techniques.1,7
Postoperative treatment includes methods to reduce antibody
load and decrease antibody production. These modalities include
plasma exchange, intravenous immunoglobulin, corticosteroid
therapy, and chemotherapy (if the teratoma is immature). Out-
comes vary depending on delay of diagnosis and neurologic func-
tioning at time of tumor removal. The largest series examining the
long-term outcome of these patients included 17-month follow-up
and showed that 47% of patients demonstrated full recovery, 28%
had mild stable deﬁcits, 18% severe deﬁcits, and 7% death.2
Although only 4 cases of anti-NMDA receptor encephalitis
associated with teratomas were described before 2005, the entity is
now reported regularly in the literature and lay press.8 This case is of
clinical importance because anti-NMDA encephalitis is emerging as
a newly recognized but likely underdiagnosed cause of neuropsy-
chiatric symptoms and fever of unknown origin. This disease has
high morbidity and mortality secondary to its often late diagnosis,
but it appears that with early detection and prompt treatment, many
of the manifestations are reversible.
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